At first blush, importing medicines sounds great – a patient without insurance or facing a high deductible or co-pay may find the prices quite attractive. But importation carries major risks.

How do doctors and insurers in the US get the info they need to make decisions about medicines for patients?

FORTUNE Magazine published its 2016 list of companies that are changing the world, and we are honored to be ranked #1.

Transparency for the sake of transparency seems a fruitless endeavor. Done right, however, it can be very powerful in strengthening relationships and forging new partnerships.

In the past three decades, we’ve made advances in treatments for HIV/AIDS but a cure has remained elusive.

How our consumer strategy is improving quality of life and access to established medicines

Putting patients’ interests at the heart of every decision.

Switching a product from a prescription medicine to over the counter (OTC) is nothing to sniff at.

Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use.

Our global commitment to helping ensure health for all is built on developing innovative medicines and vaccines and making sure they’re accessible to people around the globe.

When it comes to improving access to healthcare in Africa, markets matter. From pharmaceutical companies to small clinics, an interconnected private market complements public sector services to help patients receive the healthcare they need, when and where they need it.

Back to top